Rebalix
Amundi · sheet of 5 September 2026
Amundi · sheet of 5 September 2026ETF sheet · official issuer and register data
Amundi MSCI World Swap II UCITS ETF EUR Hedged Dist
WLDH · FR0011660927 · class EUR Hedged Dist · EUR · domicile France
Equity · GlobalEUR-hedged share classSFDR art. 6
Index tracked: MSCI World 100% Hedged to EUR Net Total Return Index
- TER
- 0.30%+ trans. 0.00%
- Fund size
- 684 m EUR
- Tracking difference
- −0.08%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Synthetic (swap)
- Income
- Mixed (acc. and/or dist.)
Launch 5 Sept 2018 · costs from the KID as of 2 Sept 2026 · 251 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Sub-fund is a passively managed index-based UCITS. The Sub-fund's objective is to replicate, both upwards and downwards, the performance of the MSCI World Net Total Return Index (net dividends reinvested) (the "Benchmark"), denominated in US dollars (USD) and representative of the performance of large- and mid-cap companies in all developed countries, while minimising the tracking error between the Fund's performance and that of the Benchmark. The expected level of the Tracking Error under normal market conditions is indicated in the Fund prospectus.…
Performance since series start (in euro) — base 100
15 Jan 2014 → 3 Sept 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +20.3% |
| 3 years | +65.0% |
| 5 years | +61.2% |
| 10 years | +192.7% |
| Since series start | +235.1% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 11.08% | 12.30% | 14.04% |
| Max drawdown | −8.48% | −17.07% | −24.01% |
| Sharpe | 1.36 | 1.03 | 0.47 |
| Sortino | 1.98 | 1.46 | 0.67 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · WLDH · FR00116609271
RebalixWLDH · FR0011660927 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +16.64% | +16.73% | −0.09% |
| 2024 | +19.82% | +19.89% | −0.07% |
| 2023 | +20.88% | +20.96% | −0.08% |
| 2022 | −17.88% | −17.87% | −0.01% |
| 2021 | +23.19% | +23.26% | −0.07% |
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 1 Sept 2026 · 251 securities · top-10 weight = 47.7%
| Top holdings | Weight |
|---|---|
| 8.3% | |
| 8.1% | |
| 6.9% | |
| 4.9% | |
| 4.8% | |
| 4.5% | |
| 2.8% | |
| 2.6% | |
| 2.5% | |
| 2.3% |
Listing venues
ESMA register (FIRDS) and official exchange lists
WLDH · Borsa Italiana (ETFplus), Euronext Paris
DJAB · Börse Düsseldorf, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
+ 17 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/FR0011660927
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/FR0011660927
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · WLDH · FR00116609272